Ledger.Open graph →
SEC Form D · filed May 22, 2017

XERIS PHARMACEUTICALS INC

Offering
$45.0M
Sold
$30.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Chicago, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Paul Edick · Chicago, ILExec · DirectorCary Mcnair · Chicago, ILDirectorJohn Shannon · Chicago, ILExecRobert Faulker · Chicago, ILDirectorNavneet Puri · Piscataway, NJDirectorBrad Huckabee · Chicago, ILExecJonathan Rigby · Austin, TXDirectorPaul Edick · Chicago, ILExec · DirectorCary Mcnair · Chicago, ILDirectorJohn Shannon · Chicago, ILExecRobert Faulker · Chicago, ILDirectorNavneet Puri · Bridgewater, NJDirectorBrad Huckabee · Chicago, ILExecJonathan Rigby · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗